PRV-3279-2a

· Provention Bio (a Sanofi Company)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRV-3279-2a, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: PRV-3279-2a Trial in Systemic Lupus [Phase 2]